Our Expert in Spain
No results available
Warranty and indemnity insurance spain has moved from a niche structuring option to a mainstream feature of cross-border transactions, and 2026 is a year in which it is standard practice on many well-advised deals. With Spanish M&A activity rising this year, buyers and sellers in the technology and life-sciences sectors are turning to W&I cover to bridge risk-allocation gaps, protect sale proceeds, and accelerate closings. This guide sets out, in the practical, step-by-step manner of a practitioner’s field manual, when W&I is appropriate, how to procure it in Spain, what it costs, how long it takes, and the Spain-specific underwriting issues that most often derail a placement.
It is written for in-house counsel, private equity and strategic buyers and sellers, transaction counsel and brokers who need to make procurement decisions, not merely read market commentary.
Who this is for: in-house counsel, PE and strategic buyers and sellers, transaction counsel and insurance brokers working on Spanish cross-border deals in tech and life sciences.
What you will get: a clear view of when W&I is appropriate in Spain, a step-by-step procurement process, typical 2026 costs and limits, the required underwriting documents, a realistic timeline, Spain-specific underwriting hotspots and the most common pitfalls to avoid.
Warranty and indemnity insurance (also called representations and warranties insurance) is a policy that transfers the financial risk of a breach of the warranties, and often the tax indemnity, given in a sale and purchase agreement (SPA) from the parties to an insurer. Instead of the buyer chasing the seller for damages, or the seller leaving part of the price locked in escrow, the loss is met by the insurer, subject to the policy terms. In Spain the underlying insurance relationship is governed by Ley 50/1980, de 8 de octubre, de Contrato de Seguro, while the corporate mechanics of the transaction itself sit under the Texto Refundido de la Ley de Sociedades de Capital (approved by Real Decreto Legislativo 1/2010).
The Spanish M&A market has rebounded strongly in 2026, with market commentators reporting a significant increase in deal value year on year, concentrated in technology, digital infrastructure and life sciences. That surge has two direct consequences for W&I. First, competitive auction processes push sellers to offer clean exits, and W&I is one of the cleanest ways to do that. Second, cross-border buyers unfamiliar with Spanish warranty practice want certainty of recovery from a rated insurer rather than from a private seller or holding vehicle. The result is rising demand for warranty and indemnity insurance spain across the mid-market and upper-mid-market.
A W&I policy responds to unknown breaches of the warranties in the SPA that the insured did not know about at signing or closing. In practice this means:
What it does not cover is equally important: known issues disclosed in due diligence or the disclosure letter, purchase-price adjustments, forward-looking projections, secondary tax liabilities and certain regulatory fines. A W&I policy is not a substitute for diligence, it is a tool that prices and transfers residual, unknown risk once diligence is done.
W&I is not right for every deal. It works best where there is a genuine, professionally advised sale process, a negotiated warranty package, and a diligence exercise the insurer can review. Warranty and indemnity insurance spain is most commonly seen on private company share sales in the mid-market and upper-mid-market range, though minimum premiums make very small deals uneconomic.
Insurers will decline, heavily condition or price out cover in a number of situations. Known liabilities identified in diligence are excluded, insurers underwrite unknown risk, not disclosed problems. Deals with thin or no third-party diligence are difficult to place because the underwriter has nothing to rely on. Distressed and insolvency sales, where warranties are minimal or non-existent, are poor candidates. Certain risk categories, environmental contamination, transfer pricing, pension underfunding, secondary tax and forward-looking financial performance, are commonly excluded or require standalone specialist cover. Very small transactions rarely justify the minimum premium.
The procurement process runs in parallel with the transaction and must be sequenced against SPA signing and closing. The following steps set out who leads and what happens at each stage. Read them alongside the timeline table below.
Who leads: Buyer or seller, with CFO and general counsel. Decide early whether the deal will use W&I, whether the policy will be buyer-side or seller-side, and set an indicative premium budget. Raising this at term-sheet stage, not the week before signing, avoids a rushed, expensive placement. A common practitioner tip is to flag the disclosure letter and diligence scope to the broker immediately, so the eventual “known loss” position is understood from day one.
Who leads: The procuring party, working with a specialist W&I broker. The broker prepares a short request-for-proposal pack, a non-binding information memorandum, draft SPA (if available), a diligence status note and the proposed warranty scope, and circulates it to insurers active in the Spanish market. Choosing a broker with genuine Spanish and cross-border M&A experience matters: they will know which underwriters are comfortable with Spanish corporate structures, Sociedades de Capital nuances and life-sciences regulatory files, and which will retreat at the first sight of them.
Who leads: Broker and insurers. Within roughly a week the broker returns non-binding indications (NBIs) from interested insurers, setting out indicative premium, limit, retention, an initial view on likely exclusions and the underwriting fee. The parties select a preferred insurer, sign the NBI and pay the underwriting fee. This is the point to compare not just headline premium but the breadth of proposed exclusions, the cheapest policy with the widest carve-outs is rarely the best value.
Who leads: Insurer’s underwriting team and their appointed counsel. The insurer reviews the full diligence package, legal, financial, tax, commercial, IP and regulatory reports, plus the data room and the near-final SPA and disclosure letter. This is the most substantive stage. In tech deals the underwriter will scrutinise IP chain-of-title and open-source usage; in life sciences they will examine AEMPS (Agencia Española de Medicamentos y Productos Sanitarios) and EMA correspondence, manufacturing authorisations and inspection history. Full, well-organised reports with clear executive summaries speed this stage materially; gaps trigger exclusions or requests for further work. The stage culminates in an underwriting call between the deal team and the insurer to walk through diligence findings.
Who leads: Buyer’s counsel and insurer’s counsel. The parties negotiate the policy against the SPA warranties, resolving coverage gaps, agreeing the definition of insured warranties, setting the limit and retention, and narrowing proposed exclusions. Alignment between the SPA warranty schedule and the policy schedule is essential: a warranty that appears in the SPA but is excluded from the policy leaves the insured exposed. Known-loss carve-outs and the treatment of the disclosure letter are the most heavily negotiated points.
Who leads: Broker and insurer. At signing the insurer issues the policy with a “no claims declaration” bring-down at closing, confirming no new breaches are known. Where signing and closing are simultaneous a single bring-down applies. The policy incepts on closing (or signing, depending on structure), and the claims and notification periods run from that date.
| Step | Who leads | Typical duration (business days) |
|---|---|---|
| 1. Strategy & budget approval | Buyer / Seller + CFO / GC | 2–5 days |
| 2. Broker selection & RFP | Buyer or Seller (with broker) | 3–7 days |
| 3. Indicative terms / termsheet | Broker / insurers | 5–10 days |
| 4. Full underwriting (insurers review DD) | Insurer underwriting team | 7–21 days |
| 5. Policy negotiation & warranty drafting | Buyer counsel + insurer counsel | 3–10 days |
| 6. Pre-closing conditions & policy issuance | Broker / insurer | 2–5 days |
| 7. Claims period & post-closing notifications | Insured party / insurer | Policy lifetime; notice deadlines per SPA |
Insurers underwrite from paper. The quality and completeness of the documentation determines both the speed of the placement and the breadth of cover. In Spain, expect insurers to accept English-language reports on cross-border deals, but corporate documents may need certified Spanish or English copies and, where documents are only in Spanish, the underwriter may require translated executive summaries. The table below sets out the standard package.
| Document category | Typical items requested | Spain-specific notes |
|---|---|---|
| Corporate documents | Articles / statutes (estatutos sociales), shareholder records, recent accounts | Certified Spanish or English copies; translator if necessary |
| Transaction documents | Draft SPA, disclosure letter, cap table, escrow arrangements | Insurers review SPA definitions of warranties and caps |
| Due diligence reports | Commercial, financial, tax, IP and regulatory DD | Redacted reports usually acceptable; executive summaries requested |
| Material contracts | Major supplier / customer agreements, licence agreements | Tech: IP assignments; life sciences: manufacturing & regulatory contracts |
| Regulatory approvals | Licences, CE markings, EMA / AEMPS correspondence | Required for life-sciences underwriting; insurers want inspection history |
| Insurance & claims history | Current policies, historic claims information | Insurers expect full claims history disclosure |
| Financial projections | Board materials and carve-out models | Supports valuation, particularly for tech scale-ups |
| Legal opinions | Title, corporate capacity, tax (if requested) | Not always required but helpful for underwriters |
A pre-underwriting checklist to run before circulating any RFP:
From a standing start, a straightforward Spanish deal can secure indicative terms in around 5–10 business days and complete full underwriting and policy issuance in a further 10–20 business days, roughly three to five weeks end-to-end. The critical path is almost always access to complete diligence reports: an insurer cannot finalise cover until it has reviewed them. Complex life-sciences matters with substantial regulatory files should allow additional time for the underwriter’s specialist review. The one immovable constraint is the SPA calendar: the policy must be negotiated and ready to incept at signing (with a closing bring-down), so W&I procurement should begin no later than the point at which the SPA and diligence reports reach near-final form.
Missing that window forces either a delayed closing or a hurried policy with wider exclusions.
The main cost of warranty and indemnity insurance spain is the premium, expressed as a percentage of the policy limit (the “rate on line”). Rates in the current Spanish market are typically in the low single digits as a percentage of the insured limit, driven by sector, deal complexity and the quality of diligence; the applicable rate should always be confirmed with a broker for the specific deal. Minimum premiums mean that below a certain deal size the effective cost becomes disproportionate.
Beyond premium, budget for the underwriting fee, broker remuneration, the retention the insured bears before the policy responds, and any applicable insurance taxes or levies, the treatment of which should be confirmed with tax counsel and against Dirección General de Seguros y Fondos de Pensiones (DGSFP) guidance.
| Cost item | Typical Spain range (indicative) | Who usually pays / notes |
|---|---|---|
| Premium (% of policy limit) | Low single-digit % of insured limit (confirm current rate with broker) | Often buyer pays for buyer policy; negotiable |
| Minimum premium | Insurer-specific minimum applies; confirm per deal | Can be significant for smaller mid-market deals |
| Broker fee | Typically a percentage of premium; confirm per engagement | Paid by the party procuring the policy |
| Retention / excess | A percentage of deal value or a fixed amount; negotiated | Sellers often accept higher retention instead of escrow |
| Limit of liability | Commonly a portion of transaction value; higher on large deals | Buyer policies often seek higher limits |
| Transaction levy / taxes | Spanish insurance premium taxes/levies may apply | Structural cost; verify with DGSFP guidance and tax counsel |
On cost allocation, the market convention is that the buyer pays for a buyer-side policy. In practice, in competitive processes sellers increasingly agree to cover part or all of the premium as a deal term, or offer a stapled solution where the cost is priced into the negotiation. There is no fixed rule, allocation is a commercial point resolved in the SPA.
The 2026 rebound in Spanish M&A has increased both demand for W&I and insurer appetite, which has generally helped keep rates competitive despite higher volumes. Most W&I capacity deployed on Spanish deals is written cross-border under the EU freedom-of-services or freedom-of-establishment regime, so placements remain subject to the EU/EEA supervisory framework for insurance (in which EIOPA plays a coordinating role) and to the domestic oversight of the Dirección General de Seguros y Fondos de Pensiones. Buyers and sellers should confirm that the underwriting entity is properly authorised to write the risk into Spain and that insurance distribution meets applicable DGSFP requirements.
Where a listed company is a party, CNMV disclosure obligations may bear on the timing of announcements and on what information can be shared with underwriters, a point to coordinate with the insurer’s confidentiality arrangements.
Escrow and W&I address the same problem, post-closing warranty exposure, through different mechanisms. Escrow retains part of the price to satisfy claims; W&I transfers the risk to an insurer. The right choice depends on the parties’ priorities on proceeds, speed and cost.
| Feature | Escrow | W&I insurance |
|---|---|---|
| Who bears net loss | Seller, until escrow released | Insurer (subject to policy terms) |
| Effect on seller proceeds | Reduces net proceeds held back | No holdback with a seller-side policy |
| Speed to close | May delay while escrow arranged | Can speed closing when buyer accepts insurance |
| Cost | Low direct cost (bank fees), but opportunity cost | Premium + broker fees, can be material |
| Claims handling | Between buyer and seller (slower) | Insurer handles claims (subject to policy) |
| Known-loss coverage | Escrow can cover identified issues | Insurers usually exclude known losses |
A practical way to read this table: escrow is cheaper in direct terms and can cover known issues, but it locks up seller proceeds and leaves claims to be fought between the parties. W&I costs more up front but delivers a clean exit, a solvent counterparty for claims, and faster closings, which is precisely why it is winning share in the competitive 2026 market. Many deals now use a hybrid: a small escrow or specific indemnity for known or excluded matters, with W&I doing the heavy lifting on unknown warranty risk.
Most disputes over W&I arise not at claim stage but from decisions taken during procurement. The recurring problems are avoidable with disciplined process and early engagement.
Warranty and indemnity insurance spain rewards early planning far more than it rewards a large budget. The single most valuable action a deal team can take is to raise W&I at term-sheet stage, scope diligence with the placement in mind, and share the disclosure letter with the insurer early to fix the known-loss boundary. Use this one-page procurement checklist as a starting point:
For deal-specific guidance on structuring, negotiating and placing warranty and indemnity insurance in Spain, connect with the M&A team through M&A lawyers, Spain (directory), or review the attributed expert’s background at the expert profile. Related guidance on negotiating reps and warranties in Spanish M&A, choosing between escrow and W&I, and the regulatory and tax issues for life-sciences deals is being published as part of this series.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Jordi Casas at Osborne Clarke, a member of the Global Law Experts network.
posted 21 seconds ago
posted 22 minutes ago
posted 43 minutes ago
posted 1 hour ago
posted 1 hour ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
No results available
Find the right Legal Expert for your business
Send welcome message